The minimally invasive operation, known as AVATAR, is performed through a small incision in the patient’s neck.

The interventional device, designed to perform both M-TEER and T-TEER, is at the center of two new studies published in EuroIntervention.

The first coronary DCB to gain FDA approval just received an additional reimbursement that could improve patient access. 

Cardiologist compensation in the United States is experiencing slow, but steady growth. How does it compare to other specialties? 

Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker. 

Researchers expected these conditions to reduce the benefits of early treatment. However, that was not the case.

Women are associated with a significantly higher rate of in-hospital disabling strokes than men, according to a new study of nearly 380,000 TAVR patients. What can cardiologists do to help limit these complications? 

Toby Rogers, MD, PhD, noted that BASILICA is a fairly complex procedure. Using this advanced technology, however, could make it easier to perform and improve patient access.

Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a new Category I CPT code for its Plaque Analysis software.

Or maybe the White House’s AI Action Plan will spur a mix of positive opportunities, negative challenges—and neutral adjustments.

PressGaney market researchers offer three observations on the technology’s potential for optimizing patient satisfaction—and, with it, subsequent ‘PX’ scores.